BRZE News & Events

In addition, Braze is reaffirming the financial guidance provided on March 24, 2026 for both the first quarter and the full year of its current fiscal year.

Isabelle Winkles, CFO, has advised the company that she will step down from her role at Braze to pursue another opportunity at a privately held company. Ms. Winkles will continue to serve as the company's CFO until May 29, 2026, overseeing the close of the current quarter and joining for the presentation of Q1 financial results to the investment community on May 27th. Thereafter, Ms. Winkles will serve in an advisory capacity through August 17, 2026 to ensure a smooth transition. The company plans to appoint Pankaj Malik, currently Chief Accounting Officer, as its Interim CFO. Mr. Malik has led the accounting department of Braze since 2021. Braze has also begun a formal search to permanently fill the CFO role.

Nick Rockwell will join the company as Chief Information Officer effective June 1, 2026. Nick will report to Braze Cofounder and Chief Technology Officer, Jon Hyman. In his role as CIO, Nick will lead initiatives related to compliance, data governance, AI transformation, enterprise business data flows, and corporate IT. Nick previously held technology and operations leadership roles at Fastly, Inc., the edge cloud platform.

The major averages closed broadly higher following reports that the U.S. has provided a plan to Iran to bring the war to an end, which sent oil prices lower. The Associated Press reported that Iran was given a 15-point proposal from the U.S. to end the conflict, though media have reported that the two sides remain far apart on a resolution and attacks from both sides have continued.Get caught up quickly on the top news and calls moving stocks with these five Top Five lists.1. STOCK NEWS:MerckTerns Pharmaceuticalsfor $53 per share in cashElon Musk's SpaceX will file an IPO prospectus as soon as this week or next,Armexpectsfrom its chips unit in five yearsChewyreportedand provided its outlook for Q1 and FY26JetBlueis exploring a potential merger with rivals,2. WALL STREET CALLS:Armto Outperform from Market Perform at Raymond JamesWolfeGeneral Motorson underappreciated potential tailwindsWedbushRezoluteas worst case scenario seems unlikely for cHIMondelezto Neutral from Buy at Rothschild & Co RedburnEVgowith Neutral from Overweight at JPMorgan3. AROUND THE WEB:Salesforceis skipping raises for its director-level and above employees, Insider reportsA jury found Metaand Googleliable in a social media addiction trial, Reuters saysMeanwhile, Metawill lay off "a few hundred people" across the company on Wednesday, The Information saysSK Hynixplans to spend about $8B on cutting-edge EUV lithography chipmaking tools from ASMLthrough 2027, Bloomberg saysInteland AMDhave each told customers they plan to raise prices across their entire CPU product lines starting in March and April, Nikkei reports4. MOVERS:Sareptarose after announcingfrom Phase 1/2 ascending dose studies of SRP-1001 and SRP-1003Brazegained afterand authorizing a stock repurchase program of up to $100MApogee Therapeuticsfinished higher after announcing aMaze Therapeuticsclosed lower afterand announcing data from its Phase 2 HORIZON trialAdma Biologicsfell for another session afterfrom Culper Research5. EARNINGS/GUIDANCE:Paychexand reaffirmed its guidance for FY26EDAP TMSand backed its guidance for FY26Cognyte, with EPS beating consensusCintasand raised its guidance for FY26QT Imagingand reaffirmed guidance for FY26INDEXES:The Dow rose 305.43, or 0.66%, to 46,429.49, the Nasdaq gained 167.93, or 0.77%, to 21,929.83, and the S&P 500 advanced 35.53, or 0.54%, to 6,591.90.